Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00481182 · ClinicalTrials.gov registry record · Phase 1
Co-Administration Of Fosamprenavir With Methadone: A Drug Interaction Study.
A Phase 1 study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
NCT00481182 is a Phase 1 study that has completed, run by GlaxoSmithKline. The registered enrollment target is 20 participants.
The verdict
NCT00481182, a Phase 1 study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
Study Summary
To assess the combined effects of fosamprenavir 700mg BID + ritonavir 100mg BID + standardized dose of methadone, on plasma total and unbound methadone enantiomer pharmacokinetics (PK), opiate pharmacodynamic (PD) measures, and safety. The effect of methadone on plasma amprenavir PK will also be assessed by comparison to historical control data.
Interventions
- DRUG fosamprenavir + ritonavir + methadone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2005-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00481182
The ClinicalTrials.gov registry entry for NCT00481182 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which fosamprenavir + ritonavir + methadone is the first listed.
NCT00481182 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00481182 about?
NCT00481182 is a clinical study titled "Co-Administration Of Fosamprenavir With Methadone: A Drug Interaction Study.". To assess the combined effects of fosamprenavir 700mg BID + ritonavir 100mg BID + standardized dose of methadone, on plasma total and unbound methadone enantiomer pharmacokinetics (PK), opiate pharmacodynamic (PD) measures, and safety. The effect of methadone on plasma amprenavir PK will also be ass...
What is the current status of trial NCT00481182?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2005-02.
What interventions are being tested in trial NCT00481182?
The interventions under investigation include: fosamprenavir + ritonavir + methadone (DRUG).
Who is sponsoring clinical trial NCT00481182?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.